Meibomian Gland Treatment (iLux)

Name: Meibomian Gland Treatment (iLux)
Brand: Boling Vision Center

iLux is an advanced, in-office meibomian gland treatment that delivers targeted heat and compression directly to the eyelids, clearing blocked glands and restoring the lipid layer essential to a stable, comfortable tear film.

Clearing the Source of Evaporative Dry Eye

Meibomian gland dysfunction is the leading cause of dry eye disease, and it's one of the most undertreated. For years, the standard approach was warm compresses at home and artificial tears as needed, neither of which addresses the blocked glands at the root of the problem.

iLux changes that. By delivering controlled, therapeutic heat and gentle compression precisely where it's needed, iLux clears obstructed meibomian glands and restores their function in a way that no drop or at-home remedy can replicate. At Boling Vision Center's Cornea & Ocular Surface Center, iLux is one of our primary tools for treating the gland dysfunction that drives evaporative dry eye.

Schedule a meibomian gland evaluation at any of our four Northern Indiana locations to find out whether iLux is the right treatment for you.

Understanding Meibomian Gland Dysfunction

The meibomian glands are a row of specialized oil-producing glands embedded in the upper and lower eyelids. Their job is to secrete a lipid-rich oil onto the tear film with each blink, forming the outermost layer that prevents tears from evaporating too quickly. When these glands become blocked or their secretions thicken, that lipid layer breaks down.

The tear film evaporates faster than it can be replenished, leaving the ocular surface exposed, irritated, and inflamed. Over time, untreated MGD can lead to permanent gland atrophy and dropout, making early treatment important not just for current symptoms but for long-term gland health.

What Is iLux?

iLux is an FDA-cleared device designed specifically to treat meibomian gland dysfunction through the application of localized heat and compression to the eyelids.

Unlike older thermal treatment systems, iLux delivers heat from both the inner and outer surfaces of the eyelid simultaneously, ensuring that the glands are thoroughly warmed before expression. A built-in light allows the provider to directly visualize the glands and their secretions throughout the treatment, enabling precise, real-time assessment of gland response.

The result is a controlled, targeted treatment that clears blocked glands more effectively than at-home measures and more comfortably than many guests expect.

How iLux Works

The iLux treatment is straightforward and well-tolerated by most guests.

Before Treatment

Your provider will evaluate your meibomian glands using imaging and direct assessment to confirm MGD and establish a baseline for measuring treatment response. The eyes are prepared with numbing drops to ensure comfort throughout the procedure.

During Treatment

The iLux device is gently applied to the eyelid, delivering controlled heat to both the inner and outer surfaces simultaneously. Once the gland contents have been sufficiently warmed and softened, gentle compression is applied to express the blocked secretions and restore gland flow.

The process is repeated across the upper and lower lids of both eyes. Most guests find the experience comfortable, with a gentle warmth and mild pressure that is well tolerated throughout.

After Treatment

There is no downtime following iLux treatment. Most guests can return to normal activities immediately. Some experience mild eyelid tenderness for a short period after the procedure, which typically resolves quickly.

What Results Can Guests Expect?

Many guests notice improvement in dry eye symptoms within the first few weeks following iLux treatment as the restored lipid layer begins to stabilize the tear film. Results vary depending on the severity of gland dysfunction and the degree of any existing gland damage.

Guests with earlier-stage MGD typically respond most robustly, which is one reason we emphasize the value of evaluation and treatment before significant gland atrophy has occurred. iLux is not a one-time cure for MGD. Most guests benefit from periodic retreatment to maintain gland function over time, alongside an ongoing care plan that may include at-home maintenance, prescription therapy, and other targeted interventions.

Friendly, caring, and just really nice! I'd definitely recommend them to friends, family, and anyone looking to get a great eye exam.

Tracee Reiter

iLux as Part of a Comprehensive Dry Eye Plan

iLux is most effective as one component of a broader, individualized dry eye treatment plan. At Boling Vision Center, we combine iLux with complementary therapies as appropriate, including prescription anti-inflammatory drops to address the inflammatory cycle that contributes to MGD, eyelid hygiene treatments to reduce bacterial biofilm and Demodex at the lid margins, and nutritional support to improve the quality of meibomian gland secretions over time. That comprehensive approach is what produces the most meaningful and lasting results.

Schedule A Consultation

Who Is a Good Candidate for iLux?

iLux is appropriate for guests with meibomian gland dysfunction contributing to evaporative dry eye symptoms. It is particularly well-suited for those who:

Have evaporative dry eye symptoms that haven't responded adequately to drops alone
Have been found on evaluation to have blocked or poorly functioning meibomian glands
Want a targeted, in-office treatment that addresses the root cause of their dry eye
Are looking to reduce dependence on artificial tears and other supportive measures

Candidacy is always confirmed through a thorough evaluation, and iLux is recommended only when the clinical picture supports it.

Why Choose Boling Vision Center?

At Boling Vision Center's Cornea & Ocular Surface Center, iLux is part of a comprehensive dry eye toolkit that includes advanced gland imaging, the full range of targeted therapies, and providers who take the time to understand what's actually driving each guest's condition. With four Northern Indiana locations and a team invested in long-term outcomes, we offer meibomian gland care that goes well beyond what most practices provide. Amazing happens here.

doctor treating a patient | glasses on racks | abstract art

Frequently Asked Questions Meibomian Gland Treatment (iLux)

Is iLux painful?

Most guests find iLux comfortable throughout. Numbing drops are applied before treatment, and the sensation during the procedure is typically described as a gentle warmth and mild pressure. Some guests experience brief tenderness around the eyelids afterward, but this is generally mild and short-lived.

How long does an iLux treatment take?

The procedure itself typically takes around 15 to 20 minutes for both eyes. When combined with the evaluation and preparation beforehand, guests should plan for an appointment of roughly 45 minutes to an hour.

How soon will I notice results?

Some guests notice improvement within a week or two of treatment as the restored lipid layer begins to stabilize the tear film. For others, the full benefit builds over several weeks. Results depend on the severity of gland dysfunction and the degree of any existing gland damage, and your provider will give you realistic expectations based on your individual evaluation.

How often will I need iLux treatment?

MGD is a chronic condition, and most guests benefit from periodic retreatment to maintain gland function over time. The specific interval varies between individuals and depends on how well gland function is maintained with at-home care and other therapies in between sessions.

Can I wear contact lenses after iLux treatment?

In most cases, yes, though your provider may recommend waiting until any post-treatment tenderness has resolved before reinserting lenses. Specific guidance will be provided based on your situation.

Will iLux help if I've had dry eye for a long time?

iLux can be beneficial even for guests with longstanding MGD, though the degree of improvement depends on how much gland function remains. Guests with significant gland atrophy or dropout may see more modest results than those with earlier-stage dysfunction, which is why we emphasize regular evaluation and timely treatment before irreversible gland loss occurs.